COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Management of Post-delivery Pain and Its Impact on Resumption of Sexuality (SMD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03953573
Recruitment Status : Recruiting
First Posted : May 16, 2019
Last Update Posted : August 4, 2020
Information provided by (Responsible Party):
Hopital Foch

Brief Summary:

Study of management of pain and information given to women post-delivery and their impact of the resumption of sexuality.

Survey to be completed by women at 8 and 15 days and 1 or 3 months after delivery.

Condition or disease Intervention/treatment
Sexuality Delivery Other: Survey

Layout table for study information
Study Type : Observational
Estimated Enrollment : 105 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Management of Post-delivery Pain and Its Impact on Resumption of Sexuality
Actual Study Start Date : December 22, 2018
Estimated Primary Completion Date : September 30, 2020
Estimated Study Completion Date : September 30, 2020

Group/Cohort Intervention/treatment
Women post-delivery Other: Survey
Survey completed at 1 day, 8 days 1 or 3 months post delivery

Primary Outcome Measures :
  1. Post-delivery sexuality resumption [ Time Frame: 3 months ]
    Time to sexuality resumption

Secondary Outcome Measures :
  1. Discussion with healthcare professional on post-delivery sexuality [ Time Frame: 1 month ]
    Number of women receiving advice from a health professional

  2. Pain post-delivery [ Time Frame: 3 months ]
    Number of women needed pain treatment or with problem for sexuality resumption

  3. Sexual health [ Time Frame: 3 months ]
    Frequency of sex

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 45 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Primiparous women, delivery at hospital.

Inclusion Criteria:

  • Primiparous woman
  • Age between 18 and 45 years old
  • Delivery after 37 weeks of amenorrhea
  • Speaking French
  • Pregnancy, delivery and new-born examination without morphologic or biometric abnormalities, respiratory distress and no pathology discovered at neonatal screening on day 3
  • Heterosexual woman with partner
  • Signed consent
  • Affiliate of national health insurance scheme

Exclusion Criteria:

  • Multiple pregnancy,
  • BMI > 30
  • Conjugopathie
  • Known psychiatric history
  • Medical history with gynecologic impact
  • Surgery history with gynecologic impacts
  • Hysterectomy post-delivery
  • Protected by French law

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT03953573

Layout table for location contacts
Contact: Elisabeth Hulier-Ammar +33(0)146251175

Layout table for location information
Hopital Foch Recruiting
Suresnes, France
Contact: Lucile Girard   
Principal Investigator: Lucile Girard         
Sponsors and Collaborators
Hopital Foch
Layout table for additonal information
Responsible Party: Hopital Foch Identifier: NCT03953573    
Other Study ID Numbers: 2018_0057
First Posted: May 16, 2019    Key Record Dates
Last Update Posted: August 4, 2020
Last Verified: July 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No